Jpmorgan Chase & CO Maia Biotechnology, Inc. Transaction History
Jpmorgan Chase & CO
- $1.23 Trillion
- Q4 2024
A detailed history of Jpmorgan Chase & CO transactions in Maia Biotechnology, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 45 shares of MAIA stock, worth $71. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45
Previous 47
4.26%
Holding current value
$71
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding MAIA
# of Institutions
19Shares Held
1.38MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA583KShares$920,3610.0% of portfolio
-
Halter Ferguson Financial Inc. Carmel, IN241KShares$380,4920.2% of portfolio
-
Geode Capital Management, LLC Boston, MA198KShares$312,0870.0% of portfolio
-
Black Rock Inc. New York, NY78.5KShares$124,0630.0% of portfolio
-
Centric Wealth Management68.2KShares$107,7860.04% of portfolio
About MAIA Biotechnology, Inc.
- Ticker MAIA
- Exchange
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,935,900
- Market Cap $17.3M
- Description
- MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company wa...